ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.28 August, 14 2023 11:30 AM Acurx Pharmaceuticals Inc. 2023-08-14 11:30:17 ET Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.28. The Company ended the second quarter with cash totaling $9.1 million compared to $9.1 million as of December 31, 2022. For further details see: Acurx Pharmaceuticals GAAP EPS of -$0.28